Novo Nordisk Executive Gordon Findlay Collapses During White House Press Conference

On November 6, 2025, during a White House press conference, Gordon Findlay, an executive from Novo Nordisk, collapsed unexpectedly. The event took place in the Oval Office as President Donald Trump announced a new agreement with pharmaceutical companies aimed at reducing drug prices and expanding access to obesity treatments.

Incident Details

Findlay was standing behind President Trump when he suddenly lost consciousness. Eyewitnesses reported that his knees gave out, prompting immediate assistance from officials present, including Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, who helped ease him to the ground. White House medical personnel responded swiftly, and press members were promptly ushered out of the room.

Official Response

Press Secretary Karoline Leavitt later confirmed the incident, stating, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.” Further details about Findlay’s condition have not been released at this time.

Background on Gordon Findlay

Gordon Findlay serves as a senior executive at Novo Nordisk, a global healthcare company specializing in diabetes care and other chronic diseases. He has been instrumental in leading initiatives aimed at improving patient access to affordable medications.

Context of the Press Conference

The press conference was convened to announce a new agreement between the federal government and major pharmaceutical companies, including Novo Nordisk. The agreement focuses on reducing drug prices and expanding access to treatments for obesity, a growing public health concern in the United States.

Next Steps

As of now, there is no further information regarding Findlay’s health status. Updates are expected as more details become available.